Xi Chen
机构:Harbin Medical University, Second Affiliated Hospital of Harbin Medical University · ORCID:0000-0001-9579-279X
发表论文 149 篇 · 总被引 5262 次 · h-index 38
代表论文
- Glycolysis related lncRNA SNHG3 / miR-139-5p / PKM2 axis promotes castration-resistant prostate cancer (CRPC) development and enzalutamide resistance (2024 · International Journal of Biological Macromolecules · 被引 28)
- A patient-derived organoid-based study identified an ASO targeting SNORD14E for endometrial cancer through reducing aberrant FOXM1 Expression and β-catenin nuclear accumulation (2023 · Journal of Experimental & Clinical Cancer Research · 被引 25)
- CDK1-mediated phosphorylation of USP37 regulates SND1 stability and promotes oncogenesis in colorectal cancer (2025 · Acta Pharmaceutica Sinica B · 被引 8)
- SNORD99 promotes endometrial cancer development by inhibiting GSDMD ‐mediated pyroptosis through 2'‐O‐methylation modification (2024 · Journal of Cellular and Molecular Medicine · 被引 8)
- SNORD9 promotes ovarian cancer tumorigenesis via METTL3/IGF2BP2-mediated NFYA m6A modification and is a potential target for antisense oligonucleotide therapy (2025 · Life Sciences · 被引 6)
- Novel co‐delivery of oridonin and docetaxel nanoliposome for an enhanced antitumor effect on esophageal cancer (2024 · The Journal of Gene Medicine · 被引 5)